Hercules Capital 

$25.22
4326
+$0.07+0.28% 今天

统计

当日最高
25.35
当日最低
25.22
52周高点
25.71
52周低点
24.42
成交量
2,703
平均成交量
1,470
市值
0
市盈率
19.68
股息率
6.21%
股息
1.57

即将到来

股息

6.21%股息率
Jan 26
$0.39
Oct 25
$0.39
Jul 25
$0.39
Apr 25
$0.39
Jan 25
$0.39
10年增长
不适用
5年增长
-0%
3年增长
-0%
1年增长
-0.01%

财报

12Feb预期
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
下一步
0.45
0.47
0.49
0.51
预期EPS
0.492321
实际EPS
不适用

财务

61.21%利润率
有盈利
2017
2018
2019
2020
2021
2022
307.26M营收
188.07M净利润

其他人也在关注

此列表基于在 Stock Events 上关注 HCXY 的用户自选生成。这不是投资建议。

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。
Ares Capital
ARCC
市值14.57B
Ares Capital Corporation是商业发展公司(BDC)领域的领先竞争对手,提供类似的金融服务和对中型企业的投资。
Golub Capital BDC
GBDC
市值3.75B
Golub Capital BDC, Inc.为中市场公司提供融资解决方案,与Hercules Capital在同一行业中直接竞争。
Prospect Capital
PSEC
市值1.24B
Prospect Capital Corporation作为一家BDC运营,投资于私人和小市值公开企业,使其成为Hercules Capital的直接竞争对手。
Main Street Capital
MAIN
市值5.09B
Main Street Capital Corporation是一家主要投资公司,专注于与Hercules Capital类似的投资策略,以中小市场公司为目标。
TriplePoint Venture Growth BDC
TPVG
市值220.57M
TriplePoint Venture Growth BDC Corp.专注于风险投资阶段的投资,与Hercules Capital专注于创新和技术驱动型公司的重点竞争。
FS KKR Capital
FSK
市值4.23B
FS KKR Capital Corp. 是一家BDC,通过为美国私人中型企业提供定制信贷解决方案与Hercules Capital竞争。
Oaktree Specialty Lending
OCSL
市值1.23B
Oaktree Specialty Lending Corporation是BDC市场上的竞争对手,专注于为中型企业提供灵活的融资解决方案。
BlackRock TCP Capital
TCPC
市值483.01M
BlackRock TCP Capital Corp. 是一家直接竞争对手,为中型企业提供债务和股权融资,类似于Hercules Capital的投资方法。
New Mountain Finance
NMFC
市值1.03B
New Mountain Finance Corporation 通过专注于债务证券和向中型企业提供贷款,类似于Hercules Capital的策略,在BDC领域竞争。
Sixth Street Specialty Lending
TSLX
市值2.13B
TPG Specialty Lending, Inc.为中市场公司提供直接贷款和融资解决方案,与Hercules Capital在同一领域竞争。

关于

Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. The firm prefers to invest between $10 million and $250 million in equity per transactions. It invests generally between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices in North America and Europe.
Show more...
首席执行官
员工
100
国家
US
ISIN
US4270968476

上市

0 Comments

分享你的想法

FAQ

Hercules Capital 今天的股价是多少?
HCXY 当前价格为 $25.22 USD,过去 24 小时上涨了 +0.28%。在图表上更密切关注 Hercules Capital 股价表现。
Hercules Capital 的股票代码是什么?
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Hercules Capital 的股票以代码 HCXY 进行交易。
Hercules Capital 的股价在上涨吗?
HCXY 股票较上周下跌 -0.21%,本月下跌 -1.25%,但在过去一年中,Hercules Capital 上涨了 +1.81%。
Hercules Capital 下一次财报日期是什么时候?
Hercules Capital 将于 二月 12, 2026 发布下一次财报。
Hercules Capital 上一季度的财报怎么样?
HCXY 上季度财报为每股 0.49 USD,预估为 0.48 USD,带来 +2.06% 的意外。下季度预估财报为每股 不适用 USD。
Hercules Capital 去年的营收是多少?
Hercules Capital 去年的营收为 307.26MUSD。
Hercules Capital 去年的净利润是多少?
HCXY 去年的净收益为 188.07MUSD。
Hercules Capital 会发放股息吗?
是的,HCXY 的股息每 每季度 发放一次。每股最新股息为 0.39 USD。截至今日,股息率(FWD)% 为 6.21%。
Hercules Capital 有多少名员工?
截至二月 02, 2026,公司共有100名员工。
Hercules Capital 属于哪个行业?
Hercules Capital从事于Financials行业。
Hercules Capital 何时完成拆股?
Hercules Capital 最近没有进行任何拆股。